PCUMH's MATCH biosystems is positioned among the 20 best biomedical companies in the world

biomedical company

The innovation of its developments has led the company to be classified as one of the twenty best companies worldwide in the biomedical sector, after placing number 19 in the 'VII China International Innovation and Entrepreneurship Competition'.


[Img # 57461]

 

MATCH biosystems, company of the Miguel Hernández University Science Park (PCUMH), has achieved an unprecedented milestone by ranking 19th in the "VII China International Innovation and Entrepreneurship Competition." This award recognizes the innovation of its diagnostic solutions for infectious diseases, especially in high-risk patients.

 

The method patented by MATCH biosystems allows the manufacture of IVD (in vitro diagnostic) kits stable at room temperature, a great logistical and economic advantage. In addition, its technology facilitates rapid and accurate diagnosis of diseases such as Invasive Candidiasis, a highly fatal type of sepsis.

 

MATCH biosystems technology not only dramatically reduces diagnosis times (from 2-5 days to just a few hours), but also prevents complications and deaths associated with these infections. This translates into significant savings for healthcare systems and a better quality of life for patients.

 

"This recognition fills us with pride and motivates us to continue working to improve people's health," he says. Adrián H. Teruel, founder and CEO of MATCH biosystems"Our goal is to become a global leader in the diagnosis of infectious diseases, especially in high-risk patients."

 

The company has competed in this event, held in the Guangming region, Shenzhen (China) with companies from Silicon Valley (United States), Germany, Israel and Japan, among others.

 

Participation in the contest in China has allowed MATCH biosystems to establish contact with investors and relevant entities in the biomedical sector. These connections open new opportunities for collaboration to expand the reach of your solutions and benefit more patients globally.

 

MATCH biosystems is made up of a team of highly qualified and experienced professionals in the field of in vitro diagnostics. The company has the IVD manufacturing license granted by the Spanish Agency for Medicines and Health Products (AEMPS) and its facilities comply with the strictest quality and biosafety standards.

 

MATCH biosystems' success at the 7th China International Innovation and Entrepreneurship Competition is a clear indication of its technology's potential to transform the landscape of infectious disease diagnostics. The company is ideally positioned to continue innovating and growing, solidifying its role as a key player in the fight against these diseases that affect millions of people worldwide.